Twisting and ironing: Doxorubicin cardiotoxicity by mitochondrial DNA damage

Clinical Cancer Research

Volumn 20, Issue 18, 2014, Pages 4737-4739

  Nitiss, Karin C ^a   Nitiss, John L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; MITOCHONDRIAL DNA;

ANIMAL; CARDIOTOXICITY; DNA DAMAGE; DRUG EFFECTS; HEART; MOUSE; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARDIOTOXICITY; DNA DAMAGE; DNA, MITOCHONDRIAL; DOXORUBICIN; HEART; MICE; MICE, TRANSGENIC;

EID: 84907447141     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-0821     Document Type: Article

References (12)

1. Khiati S, Dalla Rosa I, Sourbier C, Ma X, Rao VA, Neckers LM, et al. Mitochondrial topoisomerase I (Top1mt) is a novel limiting factor of doxorubicin cardiotoxicity. Clin Cancer Res 2014;20:4873-81.
2. Gammella E, Maccarinelli F, Buratti P, Recalcati S, Cairo G. The role of iron in anthracycline cardiotoxicity. Front Pharmacol 2014;5:25.
3. Vejpongsa P, Yeh ET. Topoisomerase 2beta: a promising molecular target for primary prevention of anthracycline-induced cardiotoxicity. Clin Pharmacol Ther 2014;95:45-52.
4. Sterba M, Popelova O, Vavrova A, Jirkovsky E, Kovarikova P, Gersl V, et al. Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. Antioxid Redox Signal 2013;18:899-929.
5. Wallace KB. Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis. Cardiovasc Toxicol 2007;7:101-7.
6. Doroshow JH. Dexrazoxane for the prevention of cardiac toxicity and treatment of extravasation injury from the anthracycline antibiotics. Curr Pharm Biotechnol 2012;13:1949-56.
7. Nitiss JL. Targeting DNA topoisomerase II in cancer chemotherapy. Nat Rev Cancer 2009;9:338-50.
8. Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 2012;18:1639-42.
9. Zhang H, Barcelo JM, Lee B, Kohlhagen G, Zimonjic DB, Popescu NC, et al. Human mitochondrial topoisomerase I. Proc Natl Acad Sci U S A 2001;98:10608-13.
10. Sobek S, Dalla Rosa I, Pommier Y, Bornholz B, Kalfalah F, Zhang H, et al. Negative regulation of mitochondrial transcription by mitochondrial topoisomerase I. Nucleic Acids Res 2013;41:9848-57.
11. Douarre C, Sourbier C, Dalla Rosa I, Brata Das B, Redon CE, Zhang H, et al. Mitochondrial topoisomerase I is critical for mitochondrial integrity and cellular energy metabolism. PLoS ONE 2012;7:e41094.
12. Maccarinelli F, Gammella E, Asperti M, Regoni M, Biasiotto G, Turco E, et al. Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity. J Mol Med 2014;92:859-69.